Hot Features
NanoLogix, Inc., a biotechnology company, provides diagnostics of viable microorganisms and viruses. It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorgani... NanoLogix, Inc., a biotechnology company, provides diagnostics of viable microorganisms and viruses. It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorganisms for pharmaceutical, industrial, veterinary, and environmental testing, as well as microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity sectors. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. NanoLogix, Inc. is based in Hubbard, Ohio. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 18671 | 0.0001 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 7479 | 5.587E-5 | CS |
| 26 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 16346 | 8.607E-5 | CS |
| 52 | 9.9E-5 | 9900 | 1.0E-6 | 0.0401 | 1.0E-6 | 187768 | 6.272E-5 | CS |
| 156 | 0 | 0 | 0.0001 | 0.0401 | 1.0E-6 | 109769 | 5.447E-5 | CS |
| 260 | -0.0179 | -99.4444444444 | 0.018 | 0.07 | 1.0E-6 | 76899 | 0.00588602 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.